EACR-AstraZeneca Cancer Epigenetics

Conference Details

Date: 05 December 2023

Time: 13:00

Duration: 2 days

Location: Online

Cost: € 20 - € 285

Organiser: EACR - European Association for Cancer Research

Conference Website

Conference Description

Epigenetic control is essential for development and differentiation, and this control mechanism is very frequently deregulated in cancer. Several small molecule inhibitors have been developed in recent years that have either been approved for clinical use or are in preclinical and clinical trials. This conference will focus on basic and clinical aspects of targeting a broad panel of epigenetic proteins in cancer, either as monotherapies, or as combination therapies, including the use of immune checkpoint inhibitors to increase drug sensitivity and overcome chemoresistance.

Target audience:

Scientists in academia and industry who are interested in how Epigenetic targeted therapy can be used for genetically targeted and combination therapies, including immune-based cancer therapies. The conference will focus on the mechanistic aspects of gene regulation and cellular plasticity, drug development as well as clinical trials using epigenetic targeted therapies.  

Topics to be covered:

• Epigenetic Regulation in Cancer Development and Maintenance;
• Novel Epigenetic Targets;
• Drug Resistance;
• Combination Therapies;
• Clinical Trials.

Scientific Programme Committee:

• Kristian Helin, UK (Chair);
• Cigall Kadoch, USA;
• Mark Dawson, Australia;
• Ho Man Chan, USA;
• Jingwen Zhang, USA.